Unexpectedly, the Myct1 KO mice displayed progressive liver glycogen accumulation instead of tumor-related phenotypes, and this finding was consistent with the iTRAQ proteomics data obtained from our tumor research, showing enrichment of a series of glycogen synthesis enzymes (data not shown). This evidence concerns the gene MYCT1 and neoplasm.